The pace of life-sciences news slowed in the past week, but we know from experience the lull is temporary. You can catch up on the headlines here:


More life-sciences news from

Denise Gellene is a former Los Angeles Times science writer and regular contributor to Xconomy. You can reach her at Illumina is a Motley Fool Stock Advisor recommendation. The Motley Fool has a disclosure policy.